FDAnews
www.fdanews.com/articles/8808-ubl-stepping-down-as-president-ceo-of-advamed-on-oct-15

Ubl Stepping Down as President, CEO of AdvaMed on Oct. 15

September 25, 2015

Stephen J. Ubl is stepping down as president and chief executive officer of AdvaMed effective Oct. 15, the association’s board of directors announced last week.

Ubl spent the last decade in the top position and has been with AdvaMed for 16 years. Board Chairman Vincent A. Forlenza praised Ubl for leading the association, as it saw significant growth in membership, policy development capabilities and advocacy impact.

The board will be conducting a national search for Ubl’s replacement. During the transition, members will work with senior staff, focusing on repealing the medical device tax in the 21st Century Cures Act and negotiating the next MDUFA. — John Bechtel